欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/3057/003
药品名称Olmesartan/Amlodipine/HCTZ "Krka"
活性成分
    • Amlodipine besilate 5.0 mg
    • Hydrochlorothiazide 25.0 mg
    • Olmesartan medoxomil 40.0 mg
剂型Film-coated tablet
上市许可持有人KRKA d.d. Novo mesto Smarjeska cesta 6 8501 Novo Mesto Slovenia
参考成员国 - 产品名称Denmark (DK)
Olmesartan/Amlodipine/HCTZ "Krka"
互认成员国 - 产品名称
    • Germany (DE)
      OlmeAmlo HCT 40 mg/5 mg/25 mg Filmtabletten
    • Belgium (BE)
      Olmesartan/Amlodipine/HCTZ Krka 40 mg/5 mg/25 mg filmomhulde tabletten
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Latvia (LV)
      Olsitri 40 mg/5 mg/25 mg apvalkotās tabletes
    • Lithuania (LT)
      Olsitri 40 mg/5 mg/25 mg plėvele dengtos tabletės
    • Estonia (EE)
      OLSITRI
    • Slovenia (SI)
许可日期2020/04/29
最近更新日期2024/10/31
药物ATC编码
    • C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
    • C09DX03 olmesartan medoxomil, amlodipine and hydrochlorothiazide
    • C09DX Angiotensin II receptor blockers (ARBs), other combinations
    • C CARDIOVASCULAR SYSTEM
    • C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase